How many valent should the HPV vaccine be for students?

Nov 12, 2023 Source: Cainiu Health

Dr. Zhao Xiaodong

Introduction

In general, the HPV vaccine refers to the human papillomavirus vaccine. Students can receive either the bivalent or the nonavalent HPV vaccine. The bivalent human papillomavirus vaccine is a passive immunizing agent; after vaccination, it can prevent cervical cancer caused by human papillomavirus types 16 and 18.

In general, the HPV vaccine refers to the human papillomavirus vaccine. Students can receive either the bivalent or the nonavalent HPV vaccine. The details are as follows:

1. Bivalent

The bivalent human papillomavirus vaccine is a passive immunizing agent. After injection, it helps prevent cervical cancer caused by human papillomavirus type 16 and human papillomavirus type 18. This vaccine is suitable for females aged 9 to 45 years.

2. Nonavalent

The nonavalent human papillomavirus vaccine provides protection against nine types of human papillomavirus infections, helping to prevent cervical cancer, genital warts, anal cancer, penile cancer, and other related diseases. It is recommended for females aged 9 to 45 years.

If students experience any discomfort, they should promptly visit a hospital for targeted treatment to avoid delays in diagnosis and care.

Related Articles

View All

Does receiving the bivalent vaccine affect nucleic acid testing?

Under normal circumstances, "bivalent" usually refers to the bivalent HPV vaccine. Whether receiving the bivalent HPV vaccine affects nucleic acid testing depends on the specific type of nucleic acid test. After vaccination, keep the injection site clean and dry, and avoid getting it wet for 24 hours to prevent infection. Avoid overeating before testing, and cooperate with healthcare personnel during nucleic acid sampling.

View Full Answer

When should the third dose of the vaccine be administered, after how many months?

In general, the timing for the third dose of a vaccine varies depending on the vaccine type. For COVID-19 vaccines, the third dose is typically administered 6 months after completing the second dose. Other vaccines, such as hepatitis B and HPV vaccines, follow fixed schedules, so the specific vaccine type must be considered to determine the appropriate interval. Before vaccination, individuals can check the vaccine type and recommended intervals through vaccination sites or official channels, and complete the vaccination on schedule.

View Full Answer

What valency of vaccine should a 32-year-old woman receive?

A 32-year-old woman is eligible for either the bivalent or quadrivalent HPV vaccine. Both the bivalent and quadrivalent vaccines effectively prevent high-risk HPV infections, offering protection for cervical health. If there is an allergy to any vaccine component or if the individual has an acute illness with fever prior to vaccination, medical evaluation is recommended. The bivalent HPV vaccine specifically targets prevention of HPV types 16 and 18.

View Full Answer

What should I do if there is a hard lump at the injection site after getting vaccinated?

A hard lump at the injection site after receiving the HPV vaccine is a common local reaction and usually resolves on its own. It can be managed by applying warm compresses to the area, avoiding pressure or irritation, keeping the site clean and dry, monitoring changes in symptoms, and adjusting daily activities as needed. If the lump continues to grow, becomes pus-filled, or is accompanied by severe pain lasting more than one week, prompt medical attention is recommended.

View Full Answer

Can a 42-year-old get the HPV vaccine?

Vaccination with the HPV vaccine is not recommended for individuals with a history of severe allergies, allergy to any vaccine component, those experiencing an acute phase of illness such as fever or cold, or those who are pregnant. Allergic reactions may lead to serious consequences; vaccination during an acute illness may affect vaccine efficacy or increase bodily stress, and the effects of vaccination on the fetus during pregnancy remain unclear.

View Full Answer

Can I get the HPV vaccine if I test positive for high-risk types HPV 16 and 18?

If HPV types 16 and 18 are positive but cervical cytology results are normal, with no evidence of cervical intraepithelial lesions or cancer, vaccination with a vaccine covering additional high-risk HPV types (such as the nine-valent or quadrivalent vaccines) may be considered. This can help prevent infection from non-16/18 high-risk HPV types, reduce the risk of subsequent infections, and lower the likelihood of various HPV-related diseases. In such cases, vaccination is generally acceptable.

View Full Answer

Who is suitable for the 9-valent human papillomavirus (HPV) vaccine?

The 9-valent human papillomavirus (HPV) vaccine is suitable for females and males aged 9 to 45 who are not allergic to any vaccine components and have no contraindications for vaccination. Individuals with fever, acute illness, or a history of severe chronic diseases prior to vaccination should seek medical evaluation to determine whether vaccination is appropriate. Immune responses in adolescents aged 9 to 15 tend to be more robust.

View Full Answer

What is the 9-valent HPV vaccine for women?

The 9-valent HPV vaccine administered to women is a vaccine that prevents human papillomavirus (HPV) infection. It covers nine high-risk and low-risk HPV subtypes, effectively reducing the risk of diseases such as cervical cancer and genital warts, making it an important protective measure for women's reproductive health. If you have any questions about vaccination or experience cervical discomfort, it is recommended to seek medical attention promptly.

View Full Answer

Your trusted source for health information and wellness guidance.

Quick Links

Resources

Connect

© 2024 HealthPortal. All rights reserved.